MENU

HELP Cybin Inc Forecast, Technical & Fundamental Analysis

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways... Show more

HELP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
HELP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMIFX9.630.11
+1.16%
Transamerica Mid Cap Growth R4
HRCVX21.460.13
+0.61%
Carillon Eagle Growth & Income A
ACGLX25.700.12
+0.47%
Invesco Growth and Income R
PMDIX22.780.01
+0.04%
Principal Small-MidCap Dividend Inc Inst
FSAKX12.33N/A
N/A
Strategic Advisers U.S. Total Stock
Cybin (HELP) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com